Current language:
- NL Nederlands
The translation of this page has been generated by machine translation.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Advies van het EMA met betrekking tot de openbaarmaking van verslagen van klinische studies met betrekking tot Humira
Correspondence - Date Monday | 02 February 2015
Case OI/3/2014/FOR - Opened on Wednesday | 16 April 2014 - Decision on Wednesday | 08 June 2016 - Institution concerned European Medicines Agency ( No further inquiries justified ) - Country France
Zie hieronder PDF.